Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tessa C, Hendrickx"'
Autor:
Eloy Moreno Roig, Arjan J. Groot, Ala Yaromina, Tessa C. Hendrickx, Lydie M. O. Barbeau, Lorena Giuranno, Glenn Dams, Jonathan Ient, Veronica Olivo Pimentel, Marike W. van Gisbergen, Ludwig J. Dubois, Marc A. Vooijs
Publikováno v:
Cells, Vol 8, Iss 1, p 45 (2019)
The hypoxia-inducible transcription factors (HIF)-1/2α are the main oxygen sensors which regulate the adaptation to intratumoral hypoxia. The aim of this study was to assess the role of the HIF proteins in regulating the radiation response of a non-
Externí odkaz:
https://doaj.org/article/a57a3bc6fa54419b86f08b433c6861ca
Autor:
Roger Habets, Kasper M.A. Rouschop, Judith Hounjet, Tessa C. Hendrickx, Lydie M. O. Barbeau, Marco B.E. Schaaf, Sanaz Yahyanejad, Marc Vooijs, Arjan J. Groot
Publikováno v:
Oncogene, 38(27), 5457-5468. Nature Publishing Group
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive cancer arising from T-cell progenitors. Although current treatments, including chemotherapy and glucocorticoids, have significantly improved survival, T-ALL remains a fatal disease and new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c38c48e80849e70d70636e4fd28f7aeb
https://doi.org/10.1038/s41388-019-0802-x
https://doi.org/10.1038/s41388-019-0802-x
Autor:
Glenn Dams, Marc Vooijs, Ala Yaromina, Marike W. van Gisbergen, Arjan J. Groot, Lydie M. O. Barbeau, Jonathan Ient, Eloy Moreno Roig, Veronica Olivo Pimentel, Ludwig Dubois, Lorena Giuranno, Tessa C. Hendrickx
Publikováno v:
Cells, Vol 8, Iss 1, p 45 (2019)
Cells
Volume 8
Issue 1
Cells, 8(1):45. Multidisciplinary Digital Publishing Institute (MDPI)
Cells
Volume 8
Issue 1
Cells, 8(1):45. Multidisciplinary Digital Publishing Institute (MDPI)
The hypoxia-inducible transcription factors (HIF)-1/2&alpha
are the main oxygen sensors which regulate the adaptation to intratumoral hypoxia. The aim of this study was to assess the role of the HIF proteins in regulating the radiation response
are the main oxygen sensors which regulate the adaptation to intratumoral hypoxia. The aim of this study was to assess the role of the HIF proteins in regulating the radiation response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6de4a491f72775db7c6014cf3aed1c80
http://www.mdpi.com/2073-4409/8/1/45
http://www.mdpi.com/2073-4409/8/1/45
Autor:
Judith, Hounjet, Roger, Habets, Marco B, Schaaf, Tessa C, Hendrickx, Lydie M O, Barbeau, Sanaz, Yahyanejad, Kasper M, Rouschop, Arjan J, Groot, Marc, Vooijs
Publikováno v:
Oncogene. 38(27)
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive cancer arising from T-cell progenitors. Although current treatments, including chemotherapy and glucocorticoids, have significantly improved survival, T-ALL remains a fatal disease and new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::33c8d6ce56d2ac81617a8668b3b4849f
https://pubmed.ncbi.nlm.nih.gov/30967635
https://pubmed.ncbi.nlm.nih.gov/30967635
Autor:
Gertjan J.L. Kaspers, Johan van Meerloo, Sonja Zweegman, Tessa C. Hendrickx, Jacqueline Cloos, Yehuda G. Assaraf, Christopher J. Kirk, Janet L. Anderl, Gerrit Jansen, Denise Niewerth
Publikováno v:
Biochemical Pharmacology, 89(1), 43-51. Elsevier Inc.
Niewerth, D, van Meerloo, J, Jansen, G, Assaraf, Y G, Hendrickx, T C, Kirk, C J, Anderl, J L, Zweegman, S, Kaspers, G J L & Cloos, J 2014, ' Anti-leukemic activity and mechanisms underlying resistance to the novel immunoproteasome inhibitor PR-924 ', Biochemical Pharmacology, vol. 89, no. 1, pp. 43-51 . https://doi.org/10.1016/j.bcp.2014.02.005
Niewerth, D, van Meerloo, J, Jansen, G, Assaraf, Y G, Hendrickx, T C, Kirk, C J, Anderl, J L, Zweegman, S, Kaspers, G J L & Cloos, J 2014, ' Anti-leukemic activity and mechanisms underlying resistance to the novel immunoproteasome inhibitor PR-924 ', Biochemical Pharmacology, vol. 89, no. 1, pp. 43-51 . https://doi.org/10.1016/j.bcp.2014.02.005
PR-924 is a novel prototypic immunoproteasome inhibitor bearing markedly enhanced specificity for the β5i immunoproteasome subunit, compared to the classical proteasome inhibitor bortezomib. Here, we assessed the growth inhibitory potential of PR-92
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad62be32358ea7ecdbd73e256a0c4a00
https://doi.org/10.1016/j.bcp.2014.02.005
https://doi.org/10.1016/j.bcp.2014.02.005
Autor:
Marco B.E. Schaaf, Tessa C. Hendrickx, Sanaz Yahyanejad, Marc Vooijs, Lydie M. O. Barbeau, Roger Habets, Kasper M.A. Rouschop, Judith Hounjet, Arjan J. Groot
Publikováno v:
ESMO Open. 3:A29-A30
Introduction T-cell acute lymphoblastic leukaemia (T-ALL) is an aggressive cancer arising from T-cell progenitors. Although current treatments, including chemotherapy and glucocorticoids, have significantly improved survival, T-ALL remains a fatal di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03e5c2087b52db9534444344f487b861
https://doi.org/10.1136/esmoopen-2018-eacr25.68
https://doi.org/10.1136/esmoopen-2018-eacr25.68
Autor:
Tessa C. Hendrickx, Johan van Meerloo, Sonja Zweegman, Denise Niewerth, Jacqueline Cloos, Gerrit Jansen, Christopher J. Kirk, Gertjan J.L. Kaspers, Yehuda G. Assaraf, Janet L. Anderl
Publikováno v:
Blood. 122:3841-3841
Proteasome inhibition with bortezomib (BTZ) is an effective treatment for hematological malignancies and an emerging treatment strategy for acute leukemia. However, the side-effects of BTZ and emergence of BTZ-resistance call for alternative therapeu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc95feab387ce304aa8b4255f27e25f0
https://doi.org/10.1182/blood.v122.21.3841.3841
https://doi.org/10.1182/blood.v122.21.3841.3841